In silico and in vitro determination of potential RSK inhibitors for colon cancer therapy

Basit Öğe Kaydı
dc.contributor.authorMulhim, U.
dc.contributor.authorTokay, E.
dc.contributor.authorKockar, F.
dc.contributor.authorKalin, S.
dc.contributor.authorOnder, F. Comert
dc.date.accessioned2025-01-27T21:24:02Z
dc.date.available2025-01-27T21:24:02Z
dc.date.issued2024
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstract[Anstract Not Available]
dc.description.sponsorshipHealth Institutes of Turkiye (TUSEB) [27777]
dc.description.sponsorshipThis study is supported by Health Institutes of Turkiye (TUSEB) (Project Number: 27777).
dc.identifier.endpage261
dc.identifier.issn2211-5463
dc.identifier.startpage261
dc.identifier.urihttps://hdl.handle.net/20.500.12428/29408
dc.identifier.volume14
dc.identifier.wosWOS:001287535501198
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofFebs Open Bio
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20250125
dc.titleIn silico and in vitro determination of potential RSK inhibitors for colon cancer therapy
dc.typeConference Object

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu